276 related articles for article (PubMed ID: 31129918)
1. Clinical significance of high-mobility group box-1 (HMGB1) in subjects with type 2 diabetes mellitus (T2DM) combined with chronic obstructive pulmonary disease (COPD).
Huang J; Zeng T; Tian Y; Wu Y; Yu J; Pei Z; Tan L
J Clin Lab Anal; 2019 Jul; 33(6):e22910. PubMed ID: 31129918
[TBL] [Abstract][Full Text] [Related]
2. Plasma HMGB-1 Levels in Subjects with Obesity and Type 2 Diabetes: A Cross-Sectional Study in China.
Wang H; Qu H; Deng H
PLoS One; 2015; 10(8):e0136564. PubMed ID: 26317615
[TBL] [Abstract][Full Text] [Related]
3. The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy.
Tai H; Wang MY; Zhao YP; Li LB; Dong QY; Liu XG; Kuang JS
Medicine (Baltimore); 2016 Aug; 95(33):e4541. PubMed ID: 27537577
[TBL] [Abstract][Full Text] [Related]
4. The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.
Dong Y; Liu J; Ma J; Quan J; Bao Y; Cui Y
Front Endocrinol (Lausanne); 2022; 13():963191. PubMed ID: 36176460
[TBL] [Abstract][Full Text] [Related]
5. High expression of high-mobility group box 1 in the blood and lungs is associated with the development of chronic obstructive pulmonary disease in smokers.
Ko HK; Hsu WH; Hsieh CC; Lien TC; Lee TS; Kou YR
Respirology; 2014 Feb; 19(2):253-261. PubMed ID: 24372740
[TBL] [Abstract][Full Text] [Related]
6. High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls.
Hou C; Zhao H; Liu L; Li W; Zhou X; Lv Y; Shen X; Liang Z; Cai S; Zou F
Mol Med; 2011; 17(7-8):807-15. PubMed ID: 21380479
[TBL] [Abstract][Full Text] [Related]
7. [The investigation of the relationship between Leptin-insulin resistance and pulmonary function in patients with chronic obstructive pulmonary disease with acute exacerbation].
Pan HY; Lu XZ; Wang DX; Zeng Y; Zhong HB
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):519-21. PubMed ID: 17767817
[TBL] [Abstract][Full Text] [Related]
8. Soluble receptor for advanced glycation end-products and progression of airway disease.
Iwamoto H; Gao J; Pulkkinen V; Toljamo T; Nieminen P; Mazur W
BMC Pulm Med; 2014 Apr; 14():68. PubMed ID: 24758342
[TBL] [Abstract][Full Text] [Related]
9. Relationship between pulmonary function and albuminuria in type 2 diabetic patients with preserved renal function.
He YY; Chen Z; Fang XY; Chang J; Lu Y; Wang XJ
BMC Endocr Disord; 2020 Jul; 20(1):112. PubMed ID: 32703207
[TBL] [Abstract][Full Text] [Related]
10. Chronic obstructive pulmonary disease, lung function and risk of type 2 diabetes: a systematic review and meta-analysis of cohort studies.
Peng Y; Zhong GC; Wang L; Guan L; Wang A; Hu K; Shen J
BMC Pulm Med; 2020 May; 20(1):137. PubMed ID: 32393205
[TBL] [Abstract][Full Text] [Related]
11. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
12. Relationship between pulmonary function and elevated glycated hemoglobin levels in health checkups: A cross-sectional observational study in Japanese participants.
Baba S; Takashima T; Hirota M; Kawashima M; Horikawa E
J Epidemiol; 2017 Nov; 27(11):511-515. PubMed ID: 28142050
[TBL] [Abstract][Full Text] [Related]
13. [Values of Body Mass Index and Chest CT Features in the Assessment of Chronic Obstructive Pulmonary Disease].
Li L; Liu Y; Li J; Gao JM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb; 42(1):55-61. PubMed ID: 32131940
[No Abstract] [Full Text] [Related]
14. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
Majumdar S; Sen S; Mandal SK
J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
[TBL] [Abstract][Full Text] [Related]
15. [Levels of HMGB1 in induced sputum from patients with asthma and chronic obstructive pulmonary disease].
Cheng Z; Kang Y; Wu QG; Dai LL; Song YN; Xia J; Si JM; Chen CY
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):2981-4. PubMed ID: 22333024
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of high mobility group box 1/toll-like receptor 4 in obese diabetic patients.
Liu S; Wang X; Kai Y; Tian C; Guo S; He L; Zhai D; Song X
Endocr J; 2022 Mar; 69(3):235-242. PubMed ID: 34657898
[TBL] [Abstract][Full Text] [Related]
17. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
[No Abstract] [Full Text] [Related]
18. Plasma Inflammatory Cytokine IL-4, IL-8, IL-10, and TNF-α Levels Correlate with Pulmonary Function in Patients with Asthma-Chronic Obstructive Pulmonary Disease (COPD) Overlap Syndrome.
Huang AX; Lu LW; Liu WJ; Huang M
Med Sci Monit; 2016 Aug; 22():2800-8. PubMed ID: 27501772
[TBL] [Abstract][Full Text] [Related]
19. Atherogenic Index of Plasma is Associated with Body Fat Level in Type 2 Diabetes Mellitus Patients.
Song P; Xu L; Xu J; Zhang HQ; Yu CX; Guan QB; Zhao M; Zhang X
Curr Vasc Pharmacol; 2018; 16(6):589-595. PubMed ID: 29299987
[TBL] [Abstract][Full Text] [Related]
20. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
